Article Text

Download PDFPDF

Use of minocycline in rheumatoid arthritis: a district general hospital experience
  1. E Suresh1,
  2. I M Morris2,
  3. P C Mattingly2
  1. 1Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK
  2. 2Kettering General Hospital, Rothwell Road, Kettering NN16 8UZ, UK
  1. Correspondence to:
    Dr E Suresh
    Rheumatic Diseases Unit, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK;

Statistics from

Double blind, randomised controlled trials have shown that minocycline is an effective disease modifying antirheumatic drug (DMARD) in rheumatoid arthritis (RA), compared with placebo1–4 or hydroxychloroquine.5 Minocycline was first used on the premise that RA may be caused by an infection but, subsequently, it was also shown to possess other properties such as matrix metalloproteinase inhibition and immunomodulation. Despite reported proof of its efficacy, most rheumatologists do not favour the use of minocycline in RA, possibly owing to availability of other “standard” DMARDs.

We performed a retrospective review of the case notes of 28 patients with RA who were prescribed minocycline. Treatment with minocycline in these patients began before the widespread availability of biological agents. Our aim was to assess the efficacy and safety of this drug in our hands compared with published trials. Our patients included 24 women …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.